BOSTON, Oct. 2 - At a panel discussion on this GSAC kickoff evening, attendees finally got a notion of what CuraGen subsidiary 454 is up to. Two years of industry buzzing paid off as Michael Weiner, 454's vice president of molecular sciences, spoke at a panel entitled "The Future of Sequencing: Advancing Toward the $1,000 Genome."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.